St Barnabas At Siskin Hospital Medicare and Medicaid Location: 1 Sisken Plaza, Chattanooga, Tennessee 37403 Ratings: Phone: (423) 847-4100 |
Nhc Healthcare, Chattanooga Medicare and Medicaid Location: 2700 Parkwood Ave, Chattanooga, Tennessee 37404 Ratings: Phone: (423) 624-1533 |
Health Center At Standifer Place, The Medicare and Medicaid Location: 2626 Walker Rd, Chattanooga, Tennessee 37421 Ratings: Phone: (423) 490-1599 |
Woodland Terrace Care And Rehab Medicare and Medicaid Location: 8249 Standifer Gap Road, Chattanooga, Tennessee 37421 Ratings: Phone: (423) 892-1716 |
Life Care Center Of Red Bank Medicare and Medicaid Location: 1020 Runyan Dr, Chattanooga, Tennessee 37405 Ratings: Phone: (423) 877-1155 |
Life Care Center Of East Ridge Medicare Location: 1502 Mcdonald Road, Chattanooga, Tennessee 37412 Ratings: Phone: (423) 894-1254 |
News Archive
The University of Illinois at Chicago has received a $7 million grant from the National Institutes of Health to study effective ways to seek, test, and treat inmates with HIV.
Packaging Coordinators, Inc. (PCI), a global supplier of pharmaceutical commercial packaging solutions and clinical trials services today announces innovative developments in its anti counterfeiting initiatives for pharmaceutical packaging. The company's new service offering is outlined in a new white paper that is available to download via PCI anti-counterfeiting white paper and details its innovative identification solution, which uses a unique identification code on each pack, generated and applied by the packer.
Reuters: "U.S. President Barack Obama, pushing for healthcare reform during a trip to conservative Montana, said on Friday the country was 'held hostage' by insurance companies that deny coverage to sick people." In what Reuters described as a "half-work, half-play trip with his family," Obama will highlight the benefits of his "$1 trillion plan to overhaul the insurance industry, expand healthcare coverage and cut costs to consumers."
UBM Medica US announces that MusculoskeletalNetwork features special coverage of sessions from the annual meeting of the American College of Rheumatology (ACR), including the latest information about new FDA processes for approval of biosimilars that are like generic versions of expensive medications now used to treat painful rheumatologic conditions such as rheumatoid arthritis (RA).
Fluoxetine was the first drug approved by the FDA for major depressive disorder (MDD) in children and adolescents, and to this date, it remains one of only two selective serotonin reuptake inhibitors (SSRIs) registered for treatment of MDD in children and adolescents, despite reports that indicate this class of drugs is associated with side effects, such as agitation, hostility and aggression.
› Verified 9 days ago